1 Min Read
Nov 28 (Reuters) - PhaseRx Inc:
* PHASERX RECEIVES POSITIVE OPINION FOR ORPHAN DRUG DESIGNATION FOR PRX-ASL FROM EUROPEAN MEDICINES AGENCY Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.